Harold G Selnick

USPTO Granted Patents = 102 (Patent Applications = 6)

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 37 (Patent Applications = 18)

Average Co-Inventor Count = 4.6

ph-index = 17

Forward Citations = 773(Granted Patents)

Forward Citations (Not Self Cited) = 709(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Ambler, NJ (US) (2008)
West Point, PA (US) (1998 - 2017)
Harleyville, PA (US) (2017)
Ambler, PA (US) (1991 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

15 out of 18

Alectos Therapeutics Inc.

patents

4. 2 out of 712

The Rockefeller University

patents

5. 1 out of 155

Simon Fraser University

patents

6. 1 out of 63

Sunesis Pharmaceuticals, Inc.

8. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2022

Loading Chart...

102 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11312723 - Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune diseases (2022-04-26),

2. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof (2021-02-09),

3. 10538512 - Aminoacylindazole immunomodulators for treatment of autoimmune diseases (2020-01-21),

4. 10022461 - Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles (2018-07-17),

5. 9938299 - Glycosidase inhibitors and uses thereof (2018-04-10),

6. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),

7. 9809537 - Glycosidase inhibitors and uses thereof (2017-11-07),

8. 9808542 - Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillary (2017-11-07),

9. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),

10. 9701693 - Selective glycosidase inhibitors and uses thereof (2017-07-11),

11. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),

12. 9670195 - Glycosidase inhibitors and uses thereof (2017-06-06),

13. 9611275 - Permeable glycosidase inhibitors and uses thereof (2017-04-04),

14. 9522883 - Glycosidase inhibitors and uses thereof (2016-12-20),

15. 9409924 - Selective glycosidase inhibitors and uses thereof (2016-08-09),

Title: Pioneering Inventor: Harold G Selnick

Introduction:

Harold G Selnick, a visionary inventor based in Ambler, PA, holds an impressive portfolio of 102 patents that have revolutionized the field of healthcare and beyond. His relentless pursuit of innovation has established him as a trailblazer in the world of invention.

Latest Patents:

Selnick's latest patents showcase his cutting-edge work in developing novel compounds for the treatment of autoimmune diseases and neurological disorders. The Pyranopyrazole and pyrazolopyridine immunomodulators demonstrate his commitment to advancing medical treatments, while the Substituted piperidines thiazolyl acetamides highlight his focus on addressing neurological and psychiatric conditions.

Career Highlights:

Throughout his career, Selnick has made significant contributions to renowned companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His innovative research and breakthrough inventions have played a crucial role in shaping the pharmaceutical industry.

Collaborations:

Selnick has collaborated with esteemed colleagues such as David A Claremon and Philippe G Nantermet, further enhancing the impact of his inventions. His teamwork and shared dedication to pushing the boundaries of science have led to the development of groundbreaking technologies.

Conclusion:

In conclusion, Harold G Selnick's passion for innovation, coupled with his relentless drive to create, has cemented his legacy as a pioneering inventor whose contributions continue to shape the world we live in today. His groundbreaking patents and collaborations serve as a testament to his unwavering dedication to advancing technology and improving lives globally.

This text is generated by artificial intelligence and may not be accurate.